skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Two independent apolipoprotein a5 Haplotypes influence human plasma triglyceride levels

Journal Article · · Human Molecular Genetics

The recently identified apolipoprotein A5 gene (APOA5) has been shown to play an important role in determining plasma triglyceride concentrations in humans and mice. We previously identified an APOA5 haplotype (designated APOA5*2) that is present in {approx}16 percent of Caucasians and is associated with increased plasma triglyceride concentrations. In this report we describe another APOA5 haplotype (APOA5*3) containing the rare allele of the single nucleotide polymorphism c.56C>G that changes serine to tryptophan at codon 19 and is independently associated with high plasma triglyceride levels in three different populations. In a sample of 264 Caucasian men and women with plasma triglyceride concentrations above the 90th percentile or below the 10th percentile, the APOA5*3 haplotype was more than three-fold more common in the group with high plasma triglyceride levels. In a second independently ascertained sample of Caucasian men and women (n 1/4 419) who were studied while consuming their self-selected diets as well as after high-carbohydrate diets and high-fat diets, the APOA5*3 haplotype was associated with increased plasma triglyceride levels on all three dietary regimens. In a third population comprising 2660 randomly selected individuals, the APOA5*3 haplotype was found in 12 percent of Caucasians, 14 percent of African-Americans and 28 percent of Hispanics and was associated with increased plasma triglyceride levels in both men and women in each ethnic group. These findings establish that the APOA5 locus contributes significantly to inter-individual variation in plasma triglyceride levels in humans. Together, the APOA5*2 and APOA5*3 haplotypes are found in 25 50 percent of African-Americans, Hispanics and Caucasians and support the contribution of common human variation to quantitative phenotypes in the general population.

Research Organization:
Lawrence Berkeley National Lab. (LBNL), Berkeley, CA (United States)
Sponsoring Organization:
USDOE Director, Office of Science. Office of Biological and Environmental Research. Life Sciences Division (US)
DOE Contract Number:
AC03-76SF00098
OSTI ID:
822955
Report Number(s):
LBNL-50367; R&D Project: GHRUB4; TRN: US200414%%410
Journal Information:
Human Molecular Genetics, Vol. 11, Issue 24; Other Information: Journal Publication Date: 2002; PBD: 16 Sep 2002
Country of Publication:
United States
Language:
English

Similar Records

Apolipoprotein A5: A newly identified gene impacting plasmatriglyceride levels in humans and mice
Journal Article · Sun Sep 15 00:00:00 EDT 2002 · Arteriosclerosis, Thrombosis and Vascular Biology(ATVB) · OSTI ID:822955

Haplotypes in the APOA1-C3-A4-A5 gene cluster affect plasma lipids in both humans and baboons
Journal Article · Mon Sep 15 00:00:00 EDT 2003 · Human Molecular Genetics · OSTI ID:822955

In Vivo Characterization of Human APOA5 Haplotypes
Journal Article · Sun Oct 01 00:00:00 EDT 2006 · Genomics · OSTI ID:822955